Tirzepatide Impact Assessment Study

NCT07740291 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Obesity & Overweight
Cardiometabolic Health Indicators
Addiction
Eating Disorders
Mental Health

Interventions

DRUG: GLP-1 Receptor Agonist Therapy
BEHAVIORAL: Structured Lifestyle Intervention

Sponsor

Texas Tech University